Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

DarioHealth (DRIO) Operating Expenses (2016 - 2025)

DarioHealth filings provide 13 years of Operating Expenses readings, the most recent being $11.4 million for Q4 2025.

  • On a quarterly basis, Operating Expenses fell 28.38% to $11.4 million in Q4 2025 year-over-year; TTM through Dec 2025 was $49.3 million, a 30.55% decrease, with the full-year FY2025 number at $49.3 million, down 30.55% from a year prior.
  • Operating Expenses hit $11.4 million in Q4 2025 for DarioHealth, down from $12.5 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $23.3 million in Q3 2021 to a low of $11.4 million in Q4 2025.
  • Median Operating Expenses over the past 5 years was $16.0 million (2023), compared with a mean of $16.5 million.
  • Biggest five-year swings in Operating Expenses: surged 309.98% in 2021 and later crashed 47.14% in 2022.
  • DarioHealth's Operating Expenses stood at $22.2 million in 2021, then crashed by 47.14% to $11.7 million in 2022, then increased by 22.19% to $14.3 million in 2023, then rose by 10.62% to $15.9 million in 2024, then dropped by 28.38% to $11.4 million in 2025.
  • The last three reported values for Operating Expenses were $11.4 million (Q4 2025), $12.5 million (Q3 2025), and $12.2 million (Q2 2025) per Business Quant data.